






































Cancer is an age-dependent disease in most mammalian 
species; in humans over 50% of cancers are found in 
people over 70 years of age [1].  Recently, the 
accumulation of senescent cells in aging tissues have 
been shown to acquire a chronic inflammatory 
phenotype (called SASP, Senescence-Associated 
Secretory Phenotype) that serves to promote the growth 
of initiated tumorigenic epithelial cells [2].  Additional 
reports have demonstrated that in the skin, the 
accumulation of senescent fibroblasts also increases the 
susceptibility of epidermal keratinocytes to 
carcinogenic initiation [3].  Therefore, while 
investigations into the role of stromal tissue on the 







































they may serve as potential emerging opportunities for 
interventional and prophylactic therapeutic strategies 
[4-6].  Our lab is investigating the role of aging in the 
development of non-melanoma skin cancer (NMSC) as 
a model for the effect that aging stromal tissue has in 
controlling carcinogenesis initiation [3, 6-10].  As such, 
the skin is an excellent model system for these studies; 
it is accessible, it has a relevant environmental 
carcinogen (UVB), and it is possible to easily 
interrogate human disease.   
 
NMSC has the highest incidence rate of all cancers 
worldwide, including an estimated 2 million newly 
diagnosed patients in the United States this year alone 
[11-12].  Although the mortality of NMSC is relatively 
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NMSC occurs primarily in geriatric individuals, it has 
been estimated that up to nearly 1% of total Medicare 
expenses in the United States go towards the treatment of 
NMSC [13].  Therefore, NMSC is a major burden on our 
healthcare system [14].  Despite our understanding for 
decades that sunlight is the main etiologic agent 
responsible for NMSC (over 90%), the incidence of 
NMSC continues to rise at an alarming rate [11].   
 
The primary environmental factor that influences the 
development of skin cancer is exposure to the spectrum 
of ultraviolet wavelengths found in sunlight.   
Furthermore, as we age our chances of developing 
NMSC greatly increases so that at age 65 we have a 
50% chance of acquiring a NMSC [15-16].  In fact, 
80% of all NMSC are diagnosed in individuals greater 
than 60 years old [15-16].  While the correlation 
between aged epidermis and NMSC is apparent, the 
mechanism responsible for this relationship remains 
obscure.  Early hypotheses describing why the 
incidence of NMSC increases with age, suggested that 
excessive sun exposure during adolescence causes 
mutations in clones of keratinocytes.  Subsequently over 
many decades of genetic selection, these initiated 
keratinocytes will form detectable tumors [17-18].   
However, recent studies have shown that more than 
77% of our lifetime sun exposure occurs after the age of 
18 [19], indicating the vast majority of damaging UVB-
irradiation takes place later in life.  In fact, more sun 
exposure occurs after age 59 (26%) than before age 18 
(23%) [19].  Recent data from a variety of labs have 
proposed a modification in the latency theory of 
carcinogenesis [20-21] based on changes in the effects 
of stromal cells (i.e. fibroblasts) on epithelial cells in 
aged individuals [22-23].  This new hypothesis states 
that the selection of initiated epithelial cells is 
accelerated in aged tissue due to alterations in gene 
expression by senescent fibroblasts supporting epithelial 
cell growth [24-26].  In addition, the aged state of cells 
may play a greater role in the initiation of carcinogenic 
DNA mutations than was previously considered [27].   
Previously we have shown that the activation of the 
insulin-like growth factor-1 receptor (IGF-1R) is critical 
for determining the response of skin keratinocytes to 
UVB irradiation in vitro and in vivo [3, 6-10].  If the 
IGF-1R is functionally inactive in vitro at the time of 
UVB-irradiation, surviving keratinocytes can continue 
to proliferate with the potential of converting the 
damaged DNA into initiating carcinogenic mutations [3, 
5-6, 10].  Recent data from our laboratories have 
indicated that similar IGF-1R-dependent UVB 
responses occur in epidermal keratinocytes in vivo [3, 5-
6, 10].  Because keratinocytes do not produce IGF-1, 
the majority of the IGF-1 supplied to the epidermis is 
produced by dermal fibroblasts.  Therefore, any 
deficiencies in dermal IGF-1 production could have 
profound effects on the response of epidermal 
keratinocytes to UVB irradiation.  We have 
demonstrated that such an instance occurs in aged skin, 
as senescent dermal fibroblasts produce significantly 
lower levels of IGF-1 than youthful, proliferating 
fibroblasts [3].  Geriatric skin with lower IGF-1 levels 
responds inappropriately to UVB exposure and results 
in the production of keratinocytes that can proliferate 
with DNA damage.  Moreover, we demonstrate that 
therapeutic treatment of geriatric skin can result in 
increased levels of dermal IGF-1 and protection against 
acute UVB-mediated formation of keratinocytes 
proliferating with DNA damage.  We hypothesize that 
the reduced activation of the IGF-1R in aging skin due 
to silencing of IGF-1 expression in senescent fibroblasts 
is an important factor in the dramatic increase in NMSC 
observed in geriatric patients.  The incorporation of 
recent data from our laboratories and these new ideas on 
the origins of cancer has led us to a new paradigm to 
explain non-melanoma skin carcinogenesis [3, 5-6, 10].  
This new paradigm indicates that the accumulation of 
senescent fibroblasts in geriatric dermis leads to a 
silencing of IGF-1 expression in the skin, resulting in a 
deficient activation of the IGF-1R in epidermal 
keratinocytes, causing an inappropriate UVB-response 
in keratinocytes, leading to proliferating keratinocytes 
containing DNA mutations, and subsequently 
photocarcinogenesis [3, 5-6].  Therefore, the 
susceptibility to develop NMSC is dependent on both the 
exposure of skin to UVB and the biologic age of the skin. 
 
Given our findings that the lack of endogenous IGF-1 
[3] in geriatric skin resulted in an inappropriate pro-
carcinogenic response to relatively low doses of UVB 
[3], and that this inappropriate response was reversed by 
local injections of exogenous IGF-1 [3], these studies 
have examined the ability of dermal wounding to 
upregulate  endogenous  IGF-1 levels and restore the 
appropriate UVB response in geriatric skin.  We 
assayed whether ablation of both the epidermis and 
papillary dermis by dermabrasion could upregulate IGF-
1 expression in geriatric skin and restore the appropriate 
UVB response.  The successful development of the 
prophylactic therapies as described here could have a 





Senescent human fibroblasts in vitro contain 
markers of the DNA damage response 
 
 Normal human fibroblasts that are continually cultured  
   











































in vitro until they reach replicative senescence have 
historically been identified by their expression of 
senescence-associated β-galactosidase [28].  Similarly, 
replicating fibroblasts treated with DNA-damaging 
chemotherapeutic drugs or pro-oxidative stressors to 
induce stress-induced senescence have been assayed for 
senescence-associated β-galactosidase activity to verify 
their senescence phenotype [3].  However, because 
identifying senescent cells using senescence-associated 
β-galactosidase requires an assay of enzymatic activity, 
its use in specimens from human tissues is not as 
effective.  Recently, it has been described that markers 
of a DNA-damage response (DDR) are found in most 
types of senescent cells, whether induced by replication 
exhaustion, reactive oxygen species, or oncogene 
expression [29-32].  To determine the reliability of 
DDR markers to identify senescent fibroblasts in skin, 
replicating, stress-induced senescent, and replicative 
senescent fibroblasts were stained by for the traditional 
senescence-associated  β-galactosidase activity, for the 
presence of 53BP1, and for the expression of cell cycle 
inhibitor p21 (Fig.1A).  As seen in Fig. 1A, senescent 
fibroblasts can be identified by nuclei which have 
greater than four 53BP1-positive foci.  When the 
numbers of senescent fibroblasts were counted in stress-
induced senescent and replicatively senescent 
fibroblasts, the use of either senescent-associated β-
galactosidase or 53BP1 foci yielded similar results (Fig. 
1B).  Therefore, markers of DDR may be useful in 
identifying senescent fibroblasts in vivo. 
 
Senescent fibroblasts accumulate in geriatric dermis 
in vivo 
  
As we age, the skin becomes altered both 
phenotypically and biologically.  The undulating 
structure of the dermal-epidermal junction in young 
skin becomes significantly flattened with age [33-34; 
Supplemental Fig. 1A].  Both the epidermis and the 
papillary dermis become atrophied in geriatric skin [33-
37; Fig. 2D] and the transcriptome in the geriatric 
dermis becomes altered, including the relative silencing 
of the IGF-1 and collagen I genes [3; Fig. 2B].   
Additionally, fibroblast morphology transforms from a 
spindle-shaped cell body and elliptical nucleus to a 
more rounded cell body and a rounded nucleus [37-38; 
Supplemental Fig. 1A, white circles].  These 
morphological changes in fibroblast shape are 
associated with increasing proportions of senescent 
fibroblasts in the papillary dermis (Fig. 2C).  These 
senescent fibroblasts can be defined in vivo by increased 
expression of DDR markers (Fig. 2A).  Previously, we 
and others have shown that senescent fibroblasts in vitro 
silence IGF-1 expression [3].  Similarly, intrinsic aging 
of skin in vivo can be characterized by a significantly 
increased proportion of senescent fibroblasts in the 
papillary dermis and a corresponding silencing of IGF-1 
expression in geriatric dermis.   
 
Dermabrasion restores young adult function in 
geriatric dermis 
 
Cosmetic dermal rejuvenation techniques have been 
widely used to stimulate the production of new collagen 
synthesis by inducing a ‘wounding response’ in the skin 
[39-40].  As such, it was of interest to determine if these 
dermal rejuvenation techniques  restored  a  more youth- 
Figure 1.  Senescent human fibroblasts contain markers
of  DNA  damage  response  in  vitro.  (A)  Low  passage
neonatal  normal  human  fibroblasts  (PD‐5),  stress‐induced
senescent fibroblasts (PD‐5, H2O2), and replicatively senescent
fibroblasts  (PD‐40)  were  stained  for  the  presence  of
senescence‐associated β‐galactosidase activity (blue), with α‐
53BP1 antibodies (multiple punctate nuclear staining), or α‐‐
p21  antibodies  (bar  =  20  μm).  (B)  The  percentage  of
senescent cells were determined for senescence‐associated β‐















































ful phenotype and biology to geriatric skin, and 
specifically to determine if these techniques could 
restore the appropriate DNA-damage response found in 
young skin to UVB-irradiated geriatric skin.  Small 
areas of sun-protected skin on geriatric volunteers were 
treated by dermabrasion.  Biopsies of dermabraded and 
untreated skin were analyzed after the treated sites were 
allowed to heal for three months.  Consistent with 
previous reports, dermabraded skin demonstrated 
increased synthesis of collagen [39-40; Supplemental 
Fig. 2] and a restoration of the dermal collagen structure 
similar to that found in young adults (Fig. 3A, panels i 








































ed atrophy of the papillary dermis (Fig. 2D) by 
significantly increasing the area of the papillary dermis 
(Fig. 3B).  The thickness of the epidermis was modestly 
increased by dermabrasion, although this result was not 
statistically significant (Fig. 3B).  Increased thickness of 
the papillary dermis was accompanied by an increase in 
fibroblast density in the dermabraded geriatric skin (Fig. 
4B; see Supplemental Fig. 3 for example of fibroblast 
verification) and statistically greater numbers of 
replicating keratinocytes and fibroblasts (Fig. 4C).  The 
increased proliferative potential of fibroblasts in the 
dermis corresponded with a decrease in the proportion 
of dermal senescent fibroblasts (Fig. 3C).  The round 
phenotype of the senescent fibroblast nuclei in control 
geriatric dermis was replaced with increasing 






by  white  arrows;  dashed  line  specifies  the  location  of  the










3mm  punch  biopsies  using  Nikon  Elements  image  analysis
software.  Asterisk indicates statistical significance from young










in  panels  ii  and  v.  Panels  iii  and  vi  are  higher  magnification
images of light boxes indicated in panels ii and v.  Panels i and iv,
bar=10  μm;  panels  ii  and  v,  bar=50  μm;  panels  iii  and  vi,
bar=12.5 μm.  (B)  The area of epidermis and papillary dermis
were  calculated  as  described  in  Fig.  2.  Asterisk  indicates
statistical  significance  from  geriatric  control  values  (Epidermis
p=0.287, Papillary dermis p=0.013; two‐tailed t‐test).  (C)  The
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in dermabraded skin can also be observed by assaying 
for DDR markers.  In contrast to the abundant 
expression of DDR markers in senescent fibroblasts of 
control geriatric dermis, DDR-positive fibroblasts are 











































Our previous data had shown that the silencing of 
endogenous IGF-1 in geriatric skin resulted in an 
inappropriate pro-carcinogenenic response to relatively 
low doses of UVB which could be reversed by local 
injections of exogenous IGF-1 [3].  Therefore, it was 
important to determine whether IGF-1 expression was 




























At three months following dermabrasion, IGF-1 
expression was three-fold higher in treated dermis 
compared to geriatric controls (Fig. 5A).  To assay the 
UVB-response, small areas of the dermabraded skin and 
untreated skin on the opposing hip/buttock were 
irradiated with 350 J/m
2 (one MED) of UVB.  Twenty-
four hours post-irradiation (the time required to clear 
TD lesions), the UVB-irradiated areas were biopsied 
and the basal layer keratinocytes were assayed for co-
expression of proliferation (Ki67) markers and UVB-
induced DNA damage (TD; see examples of scored 
keratinocytes in Supplemental Figure 4).  Consistent 
with the ability of dermabrasion to upregulate IGF-1 
levels, UVB irradiation of control versus dermabraded 
skin were similar to our findings using young skin or 
geriatric skin treated with exogenous IGF-1 (i.e., no 
keratinocytes proliferating with DNA damage in the 
dermabraded skin in contrast to significant numbers of 
Ki67+:TD+ basal keratinocytes in untreated UVB-
irradiated skin; Fig. 5B).  These findings indicate that 
dermal rejuvenation upregulates IGF-1 levels and 




We have demonstrated in vivo that geriatric skin 
accumulates increasing proportions of senescent 




biopsies  described  in  Fig.  3  were  stained  with  antibodies  to









using  Nikon  Elements  image  analysis  software.  Asterisks
indicate  statistical  significance  from  control  values  (papillary
dermis, p=0.039; epidermis p=0.058, two‐tailed t‐test).   
Figure  5.  Dermabrasion  upregulates  IGF‐1  expression
and restores the appropriate UVB response to geriatric
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of DNA-damage recognition proteins associated with 
cellular senescence [3; Fig. 3].  Furthermore, we have 
shown that geriatric skin silences IGF-1 expression [3] 
leading to deficient activation of the IGF-1R [3] on 
geriatric epidermal keratinocytes.  Therefore, when 
geriatric skin is irradiated with UVB, a portion of the 
epidermal keratinocytes respond inappropriately by 
allowing replication of UVB-damaged DNA and 
potentially creating ‘initiated’ tumor cells [3, 5-6].  The 
role of IGF-1 in vivo was confirmed by its ability to 
correct this inappropriate UVB response in geriatric 
skin by injection of IGF-1 into the dermis prior to UVB 
irradiation [3].  Thus, therapies that can restore IGF-1 
expression to levels seen in young adult dermis could 
potentially prevent the initiation of carcinogenesis in 
geriatric skin.  Skin rejuvenation techniques, including 
dermabrasion, have been widely used to stimulate 
dermal collagen production and promote a youthful 
appearance of the skin.  We found that dermabrasion of 
sun-protected geriatric skin decreased the proportion of 
senescent fibroblasts resulting in increased IGF-1 
expression.  Most importantly, dermabrasion corrected 
the inappropriate UVB response normally observed in 
geriatric skin.  These results suggest that dermabrasion 
of geriatric skin can prophylactically prevent non-
melanoma skin carcinogenesis.  
 
It is interesting to note that the use of dermabrasion to 
prophylactically treat actinic keratosis and NMSC was 
described over 40 years ago [41].  A number of reports 
have demonstrated that dermabrasion can reduce the 
incidence of actinic keratosis and NMSC up to 95% in 
susceptible individuals for many years after treatment 
[42-44].  However, the use of dermabrasion has fallen 
out of favor as a primary method for the prophylaxis of 
NMSC despite the fact that newer methods of 
prophylactic therapy, i.e. lasers, topical chemotherapy 
(5-fluorouracil, imiquimod), have never achieved the 
same level of effectiveness as dermabrasion [45-49].  In 
fact, studies of the efficacy of these modalities often use 
dermabrasion as the gold standard for NMSC 
prophylaxis [50].  
 
Although the early studies on dermabrasion 
demonstrated its success in NMSC prophylaxis, the 
mechanism of how it prevented NMSC was unclear.  It 
was hypothesized (but unproven) that the effectiveness 
of dermabrasion was due to the removal of previously 
initiated carcinogenic keratinocytes.  However, if this 
hypothesis was true, other ablative procedures should be 
just as successful in treating NMSC, but they are not.  
Our studies suggest a new mechanism by which 
dermabrasion can prevent NMSC carcinogenesis which 
focuses on its effect on dermal fibroblasts.  The 
accumulation of senescent fibroblasts in geriatric dermis 
alters the susceptibility of epidermal keratinocytes to 
accumulate and fix UVB-induced mutations in their 
genomes.  Furthermore, senescent fibroblasts have been 
shown to provide an enhanced environment for the 
growth of carcinogenically initiated epithelial cells via 
their upregulation of inflammatory cytokines [22-24].   
Therefore, the preponderance of senescent fibroblasts in 
geriatric dermis not only promotes initiating mutations 
in UVB-exposed keratinocytes but they also promote 
the expansion of initiated clones of keratinocytes.  As 
demonstrated in these studies, dermabrasion can 
dramatically reduce the proportion of senescent 
fibroblasts in treated geriatric dermis.  Importantly, the 
elimination of senescent fibroblasts restores the 
expression of IGF-1 to normal levels, increases the 
production of collagen, and prevents the inappropriate 
UVB response in epidermal keratinocytes.  These 
studies demonstrate an alternative mechanism, other 
than just removal of initiated keratinocytes, by which 





Human subjects.  Geriatric volunteers were recruited 
from patients treated at Indiana University dermatology 
clinics.  These studies were approved by the Indiana 
University School of Medicine Institutional Review 
Board and subjects have signed approved consent 
forms.  Specific requirements for inclusion/exclusion 
from these studies can be found in the Supplemental 
Materials. 
 
Dermabrasion.  Prior to treatment, a region of sun-
protected hip/buttock skin was photographed.  Next, an 
approximately 5 x 5 cm area of the subject’s lower 
hip/buttock skin was isolated and anesthetized with 
xylocaine anesthesia.  Under sterile conditions the 
localized area of skin was then abraded with sterile, 
coarse (#60) sandpaper down to the mid dermis, with 
complete removal of all epidermis and superficial 
dermis.  The wounded area was bandaged with moist, 
occlusive dressings and the volunteer was instructed to 
change the dressing twice daily until the wound is re-
epithelized in 1-2 weeks.  Approximately three months 
later (~Day 90 +/- 7 days) the volunteer returned to the 
clinic and a localized area 1 x 1 cm of either 
dermabrasion or untreated normal skin on the opposite 
hip/buttock was irradiated with dose of 350 J/m
2 of 
UVB.  In Fitzpatrick Skin Types I and II, this dose of 
UVB is sufficient to cause a minimal erythematous 
reaction.  Permanent marker was used to outline the 
areas of skin that was irradiated.  Twenty-four hours 
following UVB exposure, photographs were taken of 
   
www.impactaging.com                   412                                             AGING,    April 2011, Vol.3 No.4the skin to document the extent of the UVB reaction.  
The irradiated skin, as well as unirradiated adjacent 
skin, was removed by punch biopsy, (4 mm punch 
biopsies of the UVB-treated skin and 3 mm punch 
biopsies of unirradiated skin; 4 biopsies per individual).   
 
Human UVB response assay. The epidermal response to 
UVB irradiation was assayed as previously described 
[3].  Briefly, thin paraffin-embedded sections from 
unirradiated and UVB-irradiated biopsies were 
simultaneously stained with antibodies to Ki67 and 
thymine dimers.  Secondary antibodies that specifically 
detect only one of the primary antibodies are conjugated 
to the fluorescent dyes AlexaFluor 488 (detecting Ki67, 
emitting green wavelengths), and AlexaFluor 568 
(detecting thymine dimers, emitting red wavelengths).  
Images were captured sequentially along the entire 
length of the biopsy specimen (3mm non-irradiated, 
4mm irradiated) using a Nikon Eclipse 80i microscope 
with Intensilight epifluorescence.  These images were 
analyzed by counting the number of keratinocytes in 
contact with the basement membrane that are Ki67(+), 
thymine dimer(+), and Ki67(+):thymine dimer(+).   
These numbers were expressed as a percentage of total 
basal layer keratinocytes in the biopsy specimen 
(determined by counting basal layer keratinocytes for 
each specimen on H&E-stained slides).   
 





Supplemental Material.  Four additional figures and 
specific protocols for quantitative reverse-transcription 
PCR, immunofluorescence, growth of human 
fibroblasts, and senescence-associated  β-galactosidase 
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Supplemental Experimental Procedures 
 
Quantitative Reverse-Transcriptase PCR. Homogenized 
tissue from dissected dermal sections was lysed using 
RNeasy kit (Qiagen) buffers.  Cell lysates were then 
further homogenized using Shredder columns (Qiagen) 
and RNA isolation continued with RNeasy kit. All of 
the reagents used for RT and PCR are obtained from 
SuperArray Biosciences, Frederick, MD.  The following 
were added to a 0.2 ml tube where first a genomic DNA 
elimination step was performed on 2 μg RNA total 
volume 10 μl was heated to 42
oC for 5 minutes and 
chilled on ice.  Next the reverse transcription cocktail 
was prepared and 10 μl added to the RNA; 2 μl RT 
enzyme mix, 4 μl RT buffer, 1 μl primer and external 
control mix, 3 μl RNase free water.  Mixture was heated 
42
oC for 15 minutes, 95
oC for 5 minutes and chilled on 
ice for experiments, the final volume of cDNA was 20 
μl.  qRT-PCR is performed using a LightCycler PCR 
(Roche Scientific, Fishers IN).  Quantization of 
experimental qRT-PCR products was determined by 
comparison with external control qRT-PCR products 
from templates of a known copy number.  Relative copy 
numbers of experimental mRNA are then determined 
following adjustment with actin controls from the same 
tissue. 
 
Immunofluorescence.  Paraffin-embedded sections were 
deparaffinized, hydrated, and rinsed with tris-buffered 
saline with tween 20 (TBS) (DAKO, Carpenteria, CA).  
Antigen retrieval was performed using a water bath at 
95
oC for 20 minutes with DAKO Target Retrieval 
buffer.  After cooling, the slides are rinsed with TBS, 
and the slides were then transferred to a clean 100 mm 
bacterial glass petri dish containing PBS-saturated filter 
paper under a strip of Parafilm.  Primary antibodies 
(1:50) diluted in 3% BSA in TSB was added to the 
tissues.  The lid was placed on the petri dish and the 
coverslips incubated for 1 hour at room temperature.   
The tissues were rinsed in PBS (three 10 minutes 
washes), and then the appropriate secondary antibody 
conjugated to the desired fluorochrome was added for 
30 minutes at room temperature in the dark.  The 
sections were washed as before, the edges blotted dry, 
and then mounted with coverslips using Fluoromount G.  
Antibodies used included: α-53BP1 (Abcam, 
Cambridge, MA), α-p21 (Cell Signaling, Danvers, 
MA), α-γH2AX (Millipore, Temecula, CA), α-prolyl-4-
hydroxylase (Millipore, Temecula, CA), α-Ki67 
(NeoMarkers, Freemont, CA), and α-thymine dimers 
(Kamiya Biomedical, Seattle, WA).   
 
Senescence-associated  β-galactosidase assays. 
Fibroblasts were washed twice with PBS and fixed with 
2% formaldehyde/0.2% glutaraldehyde at room 
temperature for 10 minutes.  After two additional 
washes with PBS, 2 ml of staining solution (150 mM 
sodium chloride, 25.2 mM sodium phosphate dibasic, 
7.36 mM citric acid, 5 mM potassium ferricyanide, 5 
mM potassium ferrocyanide, 2 mM magnesium 
chloride, 1 ng/ml 5-bromo-4-chloro-3-indolyl-￿-D-
galactoside, pH 6.0)
25, were added to the cells and they 
were incubated at 37
oC overnight.  The cells were again 
washed with PBS and photographed by bright field 
microscopy to count blue cells and phase contrast 
microscopy to count total cells.  At least four fields 
(100X magnification, approximately 200 cells/field) 
were counted for each plate of cells; at least two plates 
of cells for each condition (or cell type) were assayed in 
each experiment. 
 
Isolation and culture of normal human fibroblasts.   
Excised foreskin tissue was washed with antibiotics, the 
tissue minced, and individual cells released from the 
tissue by trypsin digestion (8).  Keratinocytes and 
fibroblasts were separated by differential resistance to 
treatment with EDTA.  Fibroblasts were grown in 
Dulbecco’s Modified Eagles medium containing 10% 
fetal calf serum.  All relevant procedures using human 
tissue have been approved by the Indiana University 










































Supplementary  Figure  2.  Dermabrasion  increases  collagen  expression.





fibroblasts  was  confirmed  in  the  papillary  dermis.  Sections
were stained with antibodies to α‐prolyl‐4‐hydroxylase (red)
and  DAPI  (nuclear‐specific  stain,  blue).  Fibroblasts  stain
positive for α‐prolyl‐4‐hydroxylase and are indicated by arrows







obtained  from  the  irradiated  skin.  Sections  of  formalin‐fixed,  paraffin‐









of  the  biopsies  described  in  Fig.  2.  White  circles  indicate  elliptical  nucleus  of  a
replicating fibroblast in panel ii and the spherical nucleus of a senescent fibroblast in
panel iv.  Bar=100 μm in panels i and iii; bar=25 μm in panels ii and iv.  (B)  The density
of fibroblasts was determined in young adult and geriatric skin as described in Fig. 2
(p=0.093; two‐tailed t‐test). 